Rakesh Parikh

The drug firm reported a 3.22 percent increase in net profit to Rs. 36.2 crore for the quarter ended September 30 as sales rose.

Unichem Labs eyes favourable impact from Re fall; better Q3

In an interview to CNBC-TV18, Rakesh Parikh, VP-Finance & CFO, Unichem Labs spoke about the company‘s business performance in Q1 of FY14.

Unichem Labs earmarks Rs 120 cr for capex in FY'12

Unichem Laboratories has earmarked Rs 120 crore for capital expenditure plans in the current financial year, including the establishment of a new SEZ formulations plant and an R&D centre.

Unichem Lab gets US FDA green flag for generic drug

Rakesh Parikh, VP-finance of Unichem Laboratories, in an interview on CNBC-TV18 talks about his pharma company receiving approval from the US FDA for a new drug.

Unichem Lab's India business to grow in double digit in Q4

In an exclusive interview with CNBC-TV18, Rakesh Parikh CFO of Unichem Laboratories says the company’s Q4 outlook is on the lines of the Q3 growth and the investments made are likely to reap benefits soon. “The India formulation business is continuing in the same as in Q3. We will wrap up the year with double digit growth.”